America March 21, 2025
AstraZeneca invests $2.5B in China for R&D
In a bold move to cement its foothold in China’s booming biopharmaceutical sector, AstraZeneca announced Friday a $2.5 billion investment…
America March 21, 2025
In a bold move to cement its foothold in China’s booming biopharmaceutical sector, AstraZeneca announced Friday a $2.5 billion investment…
By Rihem Akkouche
America December 20, 2023
In a shocking turn of events, renowned migraine drug manufacturer Impel Pharmaceuticals Inc. and its subsidiary, Impel NeuroPharma Australia Pty…
By Rihem Akkouche